FR3086865B1 - OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA - Google Patents
OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA Download PDFInfo
- Publication number
- FR3086865B1 FR3086865B1 FR1859207A FR1859207A FR3086865B1 FR 3086865 B1 FR3086865 B1 FR 3086865B1 FR 1859207 A FR1859207 A FR 1859207A FR 1859207 A FR1859207 A FR 1859207A FR 3086865 B1 FR3086865 B1 FR 3086865B1
- Authority
- FR
- France
- Prior art keywords
- myopia
- progression
- inhibition
- prevention
- limitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000005764 inhibitory process Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000004515 progressive myopia Effects 0.000 title 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- 229930003347 Atropine Natural products 0.000 abstract 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 abstract 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 abstract 1
- 229960000396 atropine Drugs 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention porte sur une préparation ophtalmique comprenant de l'atropine et de l'acide hyaluronique.The present invention relates to an ophthalmic preparation comprising atropine and hyaluronic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1859207A FR3086865B1 (en) | 2018-10-04 | 2018-10-04 | OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1859207A FR3086865B1 (en) | 2018-10-04 | 2018-10-04 | OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR3086865A1 FR3086865A1 (en) | 2020-04-10 |
| FR3086865B1 true FR3086865B1 (en) | 2023-04-28 |
Family
ID=65494326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR1859207A Active FR3086865B1 (en) | 2018-10-04 | 2018-10-04 | OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR3086865B1 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (en) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Topical compsn. contg. hyaluronic acid deriv. as vehicle |
| US5612027A (en) * | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
| US5972326A (en) * | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
| US10413506B2 (en) * | 2010-04-03 | 2019-09-17 | Praful Doshi | Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia |
| CN107456440A (en) * | 2017-08-07 | 2017-12-12 | 杭州赫尔斯科技有限公司 | A kind of low concentration atropic category medicament dropping ocular fluid and preparation method thereof |
| CN107982212A (en) * | 2017-11-28 | 2018-05-04 | 杭州赫尔斯科技有限公司 | A kind of atropic category medicament slow release eye drops and preparation method thereof |
| CN108338969A (en) * | 2018-02-08 | 2018-07-31 | 胡敏 | A kind of low concentration tropane class drug eye drops and preparation method thereof |
-
2018
- 2018-10-04 FR FR1859207A patent/FR3086865B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| FR3086865A1 (en) | 2020-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53937A (en) | COMPOSITIONS COMPRISING BACTERIAL STRAINS | |
| MA49279A (en) | ANTIBODY COMPOSITIONS OPTIMIZED FOR THE TREATMENT OF EYE DISORDERS | |
| MA40306A1 (en) | Methods and formulations for the treatment of vascular ocular pathologies | |
| MA42279B1 (en) | Compositions comprising a bacterial strain of blautia hydrogenotrophica for use in the prevention or treatment of diarrhea or constipation | |
| MA45598B1 (en) | 24-hydroxy steroles substituted in position 11 for the treatment of diseases linked to the nmda receptor | |
| MA51520A (en) | 1,3,4,5-TETRAHYDRO-2H-PYRIDO [4,3-B] DERIVATIVES INDOLE FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES SUCH AS ALZHEIMER'S DISEASE | |
| MA47447B1 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer | |
| MA43763B1 (en) | Soluble and stabilized vrs pre-fusion f protein for use in the prophylaxis of vrs infection | |
| EA201992688A1 (en) | MEANS, WAYS OF APPLICATION AND METHODS OF TREATMENT | |
| MA43828A (en) | THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES | |
| MA37946B1 (en) | Use of an anti-gm-csf antibody for the treatment of rheumatoid arthritis | |
| MA44656B1 (en) | 1,5-dihydro-4h-pyrazolo [3,4-d] pyrimidin-4-ones and 1,5-dihydro-4h-pyrazolo [4,3-c] pyridin-4-ones as pde1 inhibitors | |
| MA45172B1 (en) | MODIFIED RNA ENCODING VEGF-A POLYPEPTIDES, FORMULATIONS AND USES THEREOF | |
| MA54522A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | |
| MA55490A (en) | LIPOCALIN MUTEIN FOR THE TREATMENT OF ASTHMA | |
| FR3084255B1 (en) | STREPTOCOCCUS THERMOPHILUS CNRZ160 STRAIN FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATION AND RELATED DISORDERS IN AN INDIVIDUAL | |
| MA38369B1 (en) | Peptides and compositions for the treatment of a lesion of the joint | |
| MA38425A1 (en) | Bicyclic compounds for use as selective agonists for the s1p1 receptor | |
| MA55351A (en) | NOVEL COMPOUNDS FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU PROTEIN AGGREGATES | |
| MA53551B1 (en) | CHRONIC NIGHT-TIME DOSING OF LASMIDITAN FOR THE PREVENTION OF MIGRAINE | |
| FR3086865B1 (en) | OPHTHALMIC PREPARATION AND ORTHOKERATOLOGY LENS FOR THE INHIBITION, PREVENTION AND/OR LIMITATION OF THE PROGRESSION OF MYOPIA | |
| FR3081325B1 (en) | DILTIAZEM FOR USE IN THE TREATMENT OF MICROBIAL INFECTIONS | |
| MA44660B1 (en) | (+) -AZASETRON FOR ITS USE IN THE TREATMENT OF EAR DISORDERS | |
| FR3073398B1 (en) | PENTACYCLIC TRITERPENES IN THE TREATMENT OF ORAL PATHOLOGY | |
| MA56998B1 (en) | TREATMENT OF SYMPTOMS INDUCED BY THE MENSTRUAL CYCLE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PLFP | Fee payment |
Year of fee payment: 3 |
|
| PLSC | Publication of the preliminary search report |
Effective date: 20200410 |
|
| PLFP | Fee payment |
Year of fee payment: 4 |
|
| PLFP | Fee payment |
Year of fee payment: 5 |
|
| PLFP | Fee payment |
Year of fee payment: 6 |